Ioflubenzamide I-131
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Ioflubenzamide I-131
- DrugBank Accession Number
- DB17102
- Background
Not Available
- Type
- Small Molecule
- Groups
- Investigational
- Structure
- Weight
- Average: 517.354
Monoisotopic: 517.094119008 - Chemical Formula
- C21H25FIN3O3
- Synonyms
- (131i)-n-(2-(diethylamino) ethyl-4-(4 flurobenzamido)-5-(iodo)-2-methoxybenzamide
- [131I]-N-(2-(diethylamino) ethyl-4-(4 flurobenzamido)-5-(iodo)-2-methoxybenzamide
- Benzamide, n-(2-(diethylamino)ethyl)-4-((4-fluorobenzoyl)amino)-5-(iodo-131i)-2-methoxy-
- Ioflubenzamide (131 i)
- Ioflubenzamide (131i)
- Ioflubenzamide i 131
- Ioflubenzamide, I-131
- N-(2-(diethylamino)ethyl)-4-((4-fluorobenzoyl)amino)-5-((sup 131)i)iodo-2-methoxybenzamide
- N-(2-(diethylamino)ethyl)-4-((4-fluorobenzoyl)amino)-5-(iodo-131i)-2-methoxybenzamide
- External IDs
- 131-I-MIP-1145
- 131I-MIP-1145
- BA-100
- MIP-1145 I-131
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Not Available
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 65O1D58Z6V
- CAS number
- 1214283-52-9
- InChI Key
- UPRRZQGAQRAODM-AWUWEVMDSA-N
- InChI
- InChI=1S/C21H25FIN3O3/c1-4-26(5-2)11-10-24-21(28)16-12-17(23)18(13-19(16)29-3)25-20(27)14-6-8-15(22)9-7-14/h6-9,12-13H,4-5,10-11H2,1-3H3,(H,24,28)(H,25,27)/i23+4
- IUPAC Name
- N-[2-(diethylamino)ethyl]-4-(4-fluorobenzamido)-5-(¹³¹I)iodo-2-methoxybenzamide
- SMILES
- CCN(CC)CCNC(=O)C1=C(OC)C=C(NC(=O)C2=CC=C(F)C=C2)C([131I])=C1
References
- General References
- Not Available
- External Links
- ChemSpider
- 28528966
- ChEMBL
- CHEMBL2107346
- ZINC
- ZINC000100529336
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 1 Terminated Diagnostic Metastatic Melanoma 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 0.0115 mg/mL ALOGPS logP 4.25 ALOGPS logP 3.79 Chemaxon logS -4.6 ALOGPS pKa (Strongest Acidic) 13.63 Chemaxon pKa (Strongest Basic) 9.04 Chemaxon Physiological Charge 1 Chemaxon Hydrogen Acceptor Count 4 Chemaxon Hydrogen Donor Count 2 Chemaxon Polar Surface Area 70.67 Å2 Chemaxon Rotatable Bond Count 9 Chemaxon Refractivity 123.12 m3·mol-1 Chemaxon Polarizability 47.74 Å3 Chemaxon Number of Rings 2 Chemaxon Bioavailability 1 Chemaxon Rule of Five No Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
- Chromatographic Properties
Collision Cross Sections (CCS)
Not Available
Drug created at November 14, 2022 21:18 / Updated at December 01, 2022 11:35